CRISPR Therapeutics is likely to witness an earnings beat as Casgevy sales climb and new CAR-T and in-vivo programs advance.

KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...

Thankfully, some companies can handle an inflationary environment and perform well throughout, while still registering the 12 ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!

TG Therapeutics (NASDAQ: TGTX) will release its quarterly earnings report on Monday, 2025-11-03. Here's a brief overview for investors ahead of the announcement. Analysts anticipate TG Therapeutics to ...

Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that ...

Investor Eric Jackson names Sana Biotechnology and Iris Energy as top growth picks, calling them the “Tesla of cell therapy” ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

Learn more about whether ADMA Biologics, Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor ...

The biggest insider selling lately has been at popular technology companies that have done well. The selling has been greatest at Carvana (CVNA), CoreWeave (CRWV), Atlassian (TEAM), Meta Platforms ...